Hepatitis C Stocks List

Recent Signals

Date Stock Signal Type
2021-03-05 BMY Jack-in-the-Box Bearish Bearish Swing Setup
2021-03-05 BNTC Doji - Bullish? Reversal
2021-03-05 BNTC New 52 Week Low Weakness
2021-03-05 ENTA 20 DMA Resistance Bearish
2021-03-05 GNMK Crossed Above 20 DMA Bullish
2021-03-05 GNMK Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-05 INO Hammer Candlestick Bullish
2021-03-05 INO Lower Bollinger Band Walk Weakness
2021-03-05 INO Lizard Bullish Bullish Day Trade Setup
2021-03-05 INO Doji - Bullish? Reversal
2021-03-05 IONS Lower Bollinger Band Walk Weakness
2021-03-05 IONS Stochastic Reached Oversold Weakness
2021-03-05 NNVC 180 Bullish Setup Bullish Swing Setup
2021-03-05 NNVC 1,2,3 Pullback Bullish Bullish Swing Setup
2021-03-05 NNVC Crossed Above 200 DMA Bullish
2021-03-05 NNVC Crossed Above 20 DMA Bullish
2021-03-05 NNVC Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-05 RGLS Lower Bollinger Band Walk Weakness
2021-03-05 RGLS Bullish Engulfing Bullish
2021-03-05 SCYX 50 DMA Support Bullish
2021-03-05 UTHR 50 DMA Resistance Bearish
2021-03-05 UTHR Lower Bollinger Band Walk Weakness
2021-03-05 VRTX Lower Bollinger Band Walk Weakness
2021-03-05 VRTX Bollinger Band Squeeze Range Contraction
2021-03-05 VRTX 20 DMA Resistance Bearish
2021-03-05 XTLB Pocket Pivot Bullish Swing Setup
2021-03-05 XTLB Slingshot Bearish Bearish Swing Setup
2021-03-05 XTLB Wide Range Bar Range Expansion
2021-03-05 XTLB Volume Surge Other
2021-03-05 XTLB New 52 Week High Strength
2021-03-05 XTLB Crossed Above 50 DMA Bullish
2021-03-05 XTLB Crossed Above 20 DMA Bullish

Recent News for Hepatitis C Stocks

Date Stock Title
Mar 7 VRTX Barron's Latest Picks And Pans: Lowe's, Microsoft, Vertex Pharmaceuticals, ViacomCBS And More
Mar 7 VRTX Wall Street Breakfast: The Week Ahead
Mar 7 VRTX Forget GameStop, AMC, and Sundial: These Are the Best Stocks to Buy Right Now
Mar 6 BMY Why Is Bristol Myers (BMY) Down 1.8% Since Last Earnings Report?
Mar 6 VRTX Stocks To Watch: Spotlight On DraftKings, 5G Carriers And Roblox
Mar 5 RGLS Regulus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
Mar 5 XTLB SIFY, WTI, OPEN and EVFM among notable midday movers
Mar 5 VRTX Vertex Stock Fell After a Setback on a New Drug. It’s an Opportunity for Investors.
Mar 4 BMY Amgen Acquires a Cancer Drug. Expect More Deals.
Mar 4 RGLS Will Regulus (RGLS) Report Negative Q4 Earnings? What You Should Know
Mar 4 INO INOVIO to Present at Upcoming Investor Conferences in March
Mar 3 BMY Bristol-Myers Squibb Co. (BMY) Management Presents at Cowen Virtual 41st Annual Health Care Conference Call Transcript
Mar 3 NNVC FUBO, RKT, TRXC and SOS among midday movers
Mar 3 UTHR United Therapeutics slips after the decision to discontinue Trevyent development
Mar 3 INO Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs
Mar 3 VRTX Vertex (VRTX) Down 2.4% Since Last Earnings Report: Can It Rebound?
Mar 3 UTHR Looking Into United Therapeutics's Return On Capital Employed
Mar 3 BMY Warren Buffett Buys Bristol-Myers Squibb, And So Should You
Mar 3 UTHR United Therapeutics Pulls Plug On Trevyent Development
Mar 2 BMY Bristol-Myers Squibb Co (BMY) Presents at 42nd Annual Raymond James Institutional Investor Conference (Transcript)

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver. During the initial infection people often have mild or no symptoms. Occasionally a fever, dark urine, abdominal pain, and yellow tinged skin occurs. The virus persists in the liver in about 75% to 85% of those initially infected. Early on chronic infection typically has no symptoms. Over many years however, it often leads to liver disease and occasionally cirrhosis. In some cases, those with cirrhosis will develop complications such as liver failure, liver cancer, or dilated blood vessels in the esophagus and stomach.HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment, needlestick injuries in healthcare, and transfusions. Using blood screening, the risk from a transfusion is less than one per two million. It may also be spread from an infected mother to her baby during birth. It is not spread by superficial contact. It is one of five known hepatitis viruses: A, B, C, D, and E. Diagnosis is by blood testing to look for either antibodies to the virus or its RNA. Testing is recommended in all people who are at risk.There is no vaccine against hepatitis C. Prevention includes harm reduction efforts among people who use intravenous drugs and testing donated blood. Chronic infection can be cured about 95% of the time with antiviral medications such as sofosbuvir or simeprevir. Peginterferon and ribavirin were earlier generation treatments that had a cure rate of less than 50% and greater side effects. Getting access to the newer treatments however can be expensive. Those who develop cirrhosis or liver cancer may require a liver transplant. Hepatitis C is the leading reason for liver transplantation, though the virus usually recurs after transplantation.An estimated 143 million people (2%) worldwide are infected with hepatitis C as of 2015. In 2013 about 11 million new cases occurred. It occurs most commonly in Africa and Central and East Asia. About 167,000 deaths due to liver cancer and 326,000 deaths due to cirrhosis occurred in 2015 due to hepatitis C. The existence of hepatitis C – originally identifiable only as a type of non-A non-B hepatitis – was suggested in the 1970s and proven in 1989. Hepatitis C infects only humans and chimpanzees.

More about Hepatitis C
Browse All Tags